+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Psoriasis Therapeutics Market Research Report by Molecule (Biologics and Small Molecules), Route of Administration, Dosage Forms, Mechanism of Action, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 131 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124004
UP TO OFF until Dec 31st 2022
The United States Psoriasis Therapeutics Market size was estimated at USD 3,665.57 million in 2021, USD 4,220.04 million in 2022, and is projected to grow at a CAGR 11.53% to reach USD 7,055.11 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Psoriasis Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Molecule, the market was studied across Biologics and Small Molecules.
  • Based on Route of Administration, the market was studied across Oral, Parenteral, and Topical.
  • Based on Dosage Forms, the market was studied across Liquid, Semi-solid, and Solid.
  • Based on Mechanism of Action, the market was studied across IL blocker, PDE4 Inhibitors, and TNF Inhibitors.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Psoriasis Therapeutics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Psoriasis Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Psoriasis Therapeutics Market, including AbbVie Inc., Amgen, Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., Biocon Limited, Boehringer Ingelheim International GmbH, Eli Lilly and Company, F. Hoffmann-La Roche AG, G & W Laboratories, GlaxoSmithKline plc, Johnson & Johnson services, inc, LEO Pharma A/S, mc2 therapeutics, Merck & Co., Inc., Novartis AG, Pfizer Inc, Sun Pharmaceutical Industries Limited, Temisis Therapeutics, and UCB S.A..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Psoriasis Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Psoriasis Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Psoriasis Therapeutics Market?
4. What is the competitive strategic window for opportunities in the United States Psoriasis Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the United States Psoriasis Therapeutics Market?
6. What is the market share of the leading vendors in the United States Psoriasis Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the United States Psoriasis Therapeutics Market?
Frequently Asked Questions about the U.S. Psoriasis Therapeutics Market

What is the estimated value of the U.S. Psoriasis Therapeutics Market?

The U.S. Psoriasis Therapeutics Market was estimated to be valued at $3665.57 Million in 2021.

What is the growth rate of the U.S. Psoriasis Therapeutics Market?

The growth rate of the U.S. Psoriasis Therapeutics Market is 11.5%, with an estimated value of $7055.11 Million by 2027.

What is the forecasted size of the U.S. Psoriasis Therapeutics Market?

The U.S. Psoriasis Therapeutics Market is estimated to be worth $7055.11 Million by 2027.

Who are the key companies in the U.S. Psoriasis Therapeutics Market?

Key companies in the U.S. Psoriasis Therapeutics Market include AbbVie Inc., Amgen, Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., Biocon Limited, Boehringer Ingelheim International GmbH, Eli Lilly and Company and La Roche AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Psoriasis Therapeutics Market, by Molecule
6.1. Introduction
6.2. Biologics
6.3. Small Molecules
7. Psoriasis Therapeutics Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
7.4. Topical
8. Psoriasis Therapeutics Market, by Dosage Forms
8.1. Introduction
8.2. Liquid
8.3. Semi-Solid
8.4. Solid
9. Psoriasis Therapeutics Market, by Mechanism of Action
9.1. Introduction
9.2. Il Blocker
9.3. Pde4 Inhibitors
9.4. Tnf Inhibitors
10. California Psoriasis Therapeutics Market11. Florida Psoriasis Therapeutics Market12. Illinois Psoriasis Therapeutics Market13. New York Psoriasis Therapeutics Market14. Ohio Psoriasis Therapeutics Market15. Pennsylvania Psoriasis Therapeutics Market16. Texas Psoriasis Therapeutics Market
17. Competitive Landscape
17.1. Fpnv Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, by Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. Abbvie Inc.
18.2. Amgen, Inc.
18.3. Astellas Pharma Inc.
18.4. Astrazeneca plc
18.5. Bausch Health Companies Inc.
18.6. Biocon Limited
18.7. Boehringer Ingelheim International GmbH
18.8. Eli Lilly and Company
18.9. F. Hoffmann-La Roche Ag
18.10. G & W Laboratories
18.11. GlaxoSmithKline plc
18.12. Johnson & Johnson Services, Inc
18.13. Leo Pharma A/S
18.14. Mc2 Therapeutics
18.15. Merck & Co., Inc.
18.16. Novartis Ag
18.17. Pfizer Inc
18.18. Sun Pharmaceutical Industries Limited
18.19. Temisis Therapeutics
18.20. Ucb S.A.
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES PSORIASIS THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES PSORIASIS THERAPEUTICS MARKET DYNAMICS
FIGURE 8. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2027
FIGURE 11. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 18. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ORAL, 2019-2027 (USD MILLION)
FIGURE 19. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ORAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY TOPICAL, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2021 VS 2027 (%)
FIGURE 25. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2021 VS 2027 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2027
FIGURE 27. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY LIQUID, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY LIQUID, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SEMI-SOLID, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SEMI-SOLID, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SOLID, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SOLID, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2021 VS 2027 (%)
FIGURE 34. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2021 VS 2027 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2027
FIGURE 36. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY IL BLOCKER, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY IL BLOCKER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY TNF INHIBITORS, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY TNF INHIBITORS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. CALIFORNIA PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. FLORIDA PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. ILLINOIS PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. NEW YORK PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. OHIO PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. PENNSYLVANIA PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. TEXAS PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. UNITED STATES PSORIASIS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 50. UNITED STATES PSORIASIS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 51. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES PSORIASIS THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES PSORIASIS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY LIQUID, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SEMI-SOLID, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SOLID, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY IL BLOCKER, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY TNF INHIBITORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. CALIFORNIA PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 21. CALIFORNIA PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019-2027 (USD MILLION)
TABLE 22. CALIFORNIA PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 23. CALIFORNIA PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019-2027 (USD MILLION)
TABLE 24. CALIFORNIA PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019-2027 (USD MILLION)
TABLE 25. FLORIDA PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. FLORIDA PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019-2027 (USD MILLION)
TABLE 27. FLORIDA PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 28. FLORIDA PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019-2027 (USD MILLION)
TABLE 29. FLORIDA PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019-2027 (USD MILLION)
TABLE 30. ILLINOIS PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. ILLINOIS PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019-2027 (USD MILLION)
TABLE 32. ILLINOIS PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 33. ILLINOIS PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019-2027 (USD MILLION)
TABLE 34. ILLINOIS PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019-2027 (USD MILLION)
TABLE 35. NEW YORK PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. NEW YORK PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019-2027 (USD MILLION)
TABLE 37. NEW YORK PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 38. NEW YORK PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019-2027 (USD MILLION)
TABLE 39. NEW YORK PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019-2027 (USD MILLION)
TABLE 40. OHIO PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. OHIO PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019-2027 (USD MILLION)
TABLE 42. OHIO PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 43. OHIO PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019-2027 (USD MILLION)
TABLE 44. OHIO PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019-2027 (USD MILLION)
TABLE 45. PENNSYLVANIA PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. PENNSYLVANIA PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019-2027 (USD MILLION)
TABLE 47. PENNSYLVANIA PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 48. PENNSYLVANIA PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019-2027 (USD MILLION)
TABLE 49. PENNSYLVANIA PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019-2027 (USD MILLION)
TABLE 50. TEXAS PSORIASIS THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. TEXAS PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019-2027 (USD MILLION)
TABLE 52. TEXAS PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 53. TEXAS PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019-2027 (USD MILLION)
TABLE 54. TEXAS PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES PSORIASIS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 56. UNITED STATES PSORIASIS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 57. UNITED STATES PSORIASIS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 58. UNITED STATES PSORIASIS THERAPEUTICS MARKET RANKING
TABLE 59. UNITED STATES PSORIASIS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 60. UNITED STATES PSORIASIS THERAPEUTICS MARKET MERGER & ACQUISITION
TABLE 61. UNITED STATES PSORIASIS THERAPEUTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 62. UNITED STATES PSORIASIS THERAPEUTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 63. UNITED STATES PSORIASIS THERAPEUTICS MARKET INVESTMENT & FUNDING
TABLE 64. UNITED STATES PSORIASIS THERAPEUTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 65. UNITED STATES PSORIASIS THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Amgen, Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bausch Health Companies Inc.
  • Biocon Limited
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • G & W Laboratories
  • GlaxoSmithKline plc
  • Johnson & Johnson services, inc
  • LEO Pharma A/S
  • mc2 therapeutics
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc
  • Sun Pharmaceutical Industries Limited
  • Temisis Therapeutics
  • UCB S.A.

Methodology

Loading
LOADING...